A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of RBD4059 in Participants With Stable Coronary Artery Disease
Clinical trial NCT06717074 · COMPLETED
Trial details
- NCT number
- NCT06717074
- Sponsor
- Ribocure Pharmaceuticals AB
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-28
- Primary completion
- 2026-04-29
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.